Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy

Aim. To evaluate whether patients with multiple myeloma at various risks can still benefit the same from autologous stem cell transplantation consolidation in the era of novel agents. We retrospectively analyzed 67 consecutive myeloma patients receiving autologous stem cell transplantation after bor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Tianmei, Zhou, Lili, Xi, Hao, Fu, Weijun, Du, Juan, Zhang, Chunyang, Jiang, Hua, Hou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320887/
https://www.ncbi.nlm.nih.gov/pubmed/25688273
http://dx.doi.org/10.1155/2015/613045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320887/
https://www.ncbi.nlm.nih.gov/pubmed/25688273
http://dx.doi.org/10.1155/2015/613045

Ejemplares similares